Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid β peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway
Erika Cecon, Min Chen, Marina Marçola, et al.
The FASEB Journal (2015) Vol. 29, Iss. 6, pp. 2566-2582
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Update on melatonin receptors: IUPHAR Review 20
Ralf Jockers, Philippe Delagrange, Margarita L. Dubocovich, et al.
British Journal of Pharmacology (2016) Vol. 173, Iss. 18, pp. 2702-2725
Open Access | Times Cited: 376
Protective role of melatonin in cardiac ischemia‐reperfusion injury: From pathogenesis to targeted therapy
Hao Zhou, Qiang Ma, Pingjun Zhu, et al.
Journal of Pineal Research (2018) Vol. 64, Iss. 3
Open Access | Times Cited: 219
Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management
K. B. Megha, A. Arathi, Saini Shikha, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5541-5571
Closed Access | Times Cited: 18
Immune‐pineal axis – acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes
Regina P. Markus, Pedro Augusto Carlos Magno Fernandes, Gabriela Sarti Kinker, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 16, pp. 3239-3250
Open Access | Times Cited: 166
Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation
Ning Ma, Jie Zhang, Rüssel J. Reiter, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 2, pp. 606-632
Closed Access | Times Cited: 128
Melatonin: A potential nighttime guardian against Alzheimer’s
Z Zhang, Pei Xue, Barbara B. Bendlin, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 11
Protective Effect of the Novel Melatonin Analogue Containing Donepezil Fragment on Memory Impairment via MT/ERK/CREB Signaling in the Hippocampus in a Rat Model of Pinealectomy and Subsequent Aβ1-42 Infusion
Jana Tchekalarova, Petya Ivanova, Desislava Krushovlieva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1867-1867
Open Access | Times Cited: 8
Melatoninergic System in Parkinson’s Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
Josiel Mileno Mack, Marissa Giovanna Schamne, Tuane Bazanella Sampaio, et al.
Oxidative Medicine and Cellular Longevity (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 74
Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
Juhyun Song
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 68
Systematic protein–protein interaction mapping for clinically relevant human GPCRs
Kate Sokolina, Saranya Kittanakom, Jamie Snider, et al.
Molecular Systems Biology (2017) Vol. 13, Iss. 3
Open Access | Times Cited: 66
Possible Role of Pineal and Extra-Pineal Melatonin in Surveillance, Immunity, and First-Line Defense
Regina P. Markus, Kassiano dos Santos Sousa, Sanseray da Silveira Cruz‐Machado, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12143-12143
Open Access | Times Cited: 44
Dual Effect of Catecholamines and Corticosterone Crosstalk on Pineal Gland Melatonin Synthesis
Pedro Augusto Carlos Magno Fernandes, Eduardo Koji Tamura, Letícia D'Argenio-Garcia, et al.
Neuroendocrinology (2016) Vol. 104, Iss. 2, pp. 126-134
Closed Access | Times Cited: 60
Design and validation of the first cell‐impermeant melatonin receptor agonist
Florence Gbahou, Erika Cecon, Guillaume Viault, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 14, pp. 2409-2421
Open Access | Times Cited: 59
Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease
Trongha Phan, Roneil G. Malkani
Neurobiology of Stress (2018) Vol. 10, pp. 100133-100133
Open Access | Times Cited: 52
Protective roles of melatonin against the amyloid-dependent development of Alzheimer’s disease: A critical review
Bruno Vincent
Pharmacological Research (2018) Vol. 134, pp. 223-237
Closed Access | Times Cited: 51
The RelA/cRel nuclear factor‐κB (NF‐κB) dimer, crucial for inflammation resolution, mediates the transcription of the key enzyme in melatonin synthesis in RAW 264.7 macrophages
Sandra Márcia Muxel, Maria Fernanda Laranjeira‐Silva, Claudia Emanuelle Carvalho‐Sousa, et al.
Journal of Pineal Research (2016) Vol. 60, Iss. 4, pp. 394-404
Closed Access | Times Cited: 49
Tumour Microenvironment: Roles of the Aryl Hydrocarbon Receptor, O-GlcNAcylation, Acetyl-CoA and Melatonergic Pathway in Regulating Dynamic Metabolic Interactions across Cell Types—Tumour Microenvironment and Metabolism
George Anderson
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 141-141
Open Access | Times Cited: 39
Emerging biotechnologies for evaluating disruption of stress, sleep, and circadian rhythm mechanism using aptamer-based detection of salivary biomarkers
Meenakshi Pundir, Silvana Papagerakis, Maria C. De Rosa, et al.
Biotechnology Advances (2022) Vol. 59, pp. 107961-107961
Open Access | Times Cited: 27
Inhibition of hippocampal melatonin synthesis by siRNA induced learning and memory deficits in male rats
Tahereh Ghorbandaiepour, Esmaeil Sadroddiny, Maryam Zahmatkesh, et al.
Hormones and Behavior (2024) Vol. 164, pp. 105599-105599
Closed Access | Times Cited: 4
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State
Alessandro Martorana, Francesco Di Lorenzo, Lorena Belli, et al.
CNS Neuroscience & Therapeutics (2015) Vol. 21, Iss. 12, pp. 921-925
Open Access | Times Cited: 45
Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer’s disease via C/EBPα/miR‐125b pathway
Hui Tang, Mei Ma, Ying Wu, et al.
Aging Cell (2019) Vol. 18, Iss. 2
Open Access | Times Cited: 38
Melatonin MT1 and MT2 receptor ERK signaling is differentially dependent on Gi/o and Gq/11 proteins
Min Chen, Erika Cecon, Angeliki Karamitri, et al.
Journal of Pineal Research (2020) Vol. 68, Iss. 4
Closed Access | Times Cited: 37
Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
Victoria M. Pak, S.‐Hakki Onen, Donald L. Bliwise, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 37
Long-term oral melatonin alleviates memory deficits, reduces amyloid-β deposition associated with downregulation of BACE1 and mitophagy in APP/PS1 transgenic mice
Cuimei Sun, Xueliang Qiu, Ying Wang, et al.
Neuroscience Letters (2020) Vol. 735, pp. 135192-135192
Closed Access | Times Cited: 36
Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
Aditi Giri, Sidharth Mehan, Zuber Khan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 6, pp. 3867-3895
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top